Guizhounli Pharmaceutical Co (SHSE:603439) Other Operating Expense : ¥102 Mil (TTM As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Guizhounli Pharmaceutical Co Other Operating Expense?

Guizhounli Pharmaceutical Co's Other Operating Expense for the three months ended in Jun. 2024 was ¥56 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 was ¥102 Mil.

Guizhounli Pharmaceutical Co's quarterly Other Operating Expense declined from Dec. 2023 (¥63 Mil) to Mar. 2024 (¥4 Mil) but then increased from Mar. 2024 (¥4 Mil) to Jun. 2024 (¥56 Mil).

Guizhounli Pharmaceutical Co's annual Other Operating Expense increased from Dec. 2021 (¥24 Mil) to Dec. 2022 (¥37 Mil) and increased from Dec. 2022 (¥37 Mil) to Dec. 2023 (¥65 Mil).

Guizhounli Pharmaceutical Co Other Operating Expense Historical Data

The historical data trend for Guizhounli Pharmaceutical Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guizhounli Pharmaceutical Co Other Operating Expense Chart

Guizhounli Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

26.22

20.91

24.29

36.62

65.00

Guizhounli Pharmaceutical Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Other Operating Expense	Get a 7-Day Free Trial															19.97	-20.10	62.67	3.51	56.40

Guizhounli Pharmaceutical Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥102 Mil.

Guizhounli Pharmaceutical Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Guizhounli Pharmaceutical Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Guizhounli Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Guizhou Sanli Pharmaceutical Co Ltd (SHSE:603439) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Xiayun Industrial Park, Pingba District, Guizhou Province, Anshun, CHN, 561000

Website

http://www.gz-sanli.com

Guizhou Sanli Pharmaceutical Co Ltd is engaged in Chinese pharmaceutical research, development, production and marketing. The company produces and sells soft capsules, hard capsules, sprays (including Chinese medicine extraction) and provides Chinese medicine science and technology consulting services. Its products include Pediatric medication; Respiratory system medication; Cardiovascular and cerebrovascular drugs; Digestive medicine; Trauma injury medication; Rehabilitation medicine; and Ophthalmic medicine.

Executives

Zhang Hong Yu	Directors, senior managers
Wang Yi	senior management
Zhang Qian Fan	Directors, senior managers
Sheng Yong Jian	Director

Guizhounli Pharmaceutical Co Headlines

No Headlines